EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis
Europe - FRA:ESF0 - FR0014000MR3 - Common Stock
59.82 EUR
-0.3 (-0.5%)
Taking everything into account, ESF0 scores 6 out of 10 in our fundamental rating. ESF0 was compared to 18 industry peers in the Life Sciences Tools & Services industry. ESF0 has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on ESF0. With these ratings, ESF0 could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
ESF0 had positive earnings in the past year.
In the past year ESF0 had a positive cash flow from operations.
Each year in the past 5 years ESF0 has been profitable.
In the past 5 years ESF0 always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of 3.54%, ESF0 perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
The Return On Equity of ESF0 (8.09%) is comparable to the rest of the industry.
ESF0 has a Return On Invested Capital of 9.79%. This is in the better half of the industry: ESF0 outperforms 77.78% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ESF0 is in line with the industry average of 7.57%.
The last Return On Invested Capital (9.79%) for ESF0 is above the 3 year average (8.70%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROIC | 9.79% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
1.3 Margins
ESF0's Profit Margin of 5.44% is on the low side compared to the rest of the industry. ESF0 is outperformed by 66.67% of its industry peers.
ESF0's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 15.59%, ESF0 is in line with its industry, outperforming 50.00% of the companies in the same industry.
ESF0's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 23.29%, ESF0 is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
ESF0's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% |
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ESF0 is still creating some value.
The number of shares outstanding for ESF0 has been reduced compared to 1 year ago.
ESF0 has more shares outstanding than it did 5 years ago.
ESF0 has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.66 indicates that ESF0 is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ESF0 (2.66) is comparable to the rest of the industry.
ESF0 has a debt to FCF ratio of 5.25. This is a neutral value as ESF0 would need 5.25 years to pay back of all of its debts.
The Debt to FCF ratio of ESF0 (5.25) is better than 66.67% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that ESF0 is somewhat dependend on debt financing.
ESF0 has a Debt to Equity ratio of 0.77. This is in the lower half of the industry: ESF0 underperforms 72.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.25 | ||
| Altman-Z | 2.66 |
ROIC/WACC1.3
WACC7.52%
2.3 Liquidity
ESF0 has a Current Ratio of 1.26. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.26, ESF0 is doing worse than 61.11% of the companies in the same industry.
A Quick Ratio of 1.19 indicates that ESF0 should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.19, ESF0 is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.50% over the past year.
ESF0 shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.34% yearly.
Looking at the last year, ESF0 shows a small growth in Revenue. The Revenue has grown by 2.53% in the last year.
Measured over the past years, ESF0 shows a quite strong growth in Revenue. The Revenue has been growing by 8.78% on average per year.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
3.2 Future
The Earnings Per Share is expected to grow by 13.34% on average over the next years. This is quite good.
Based on estimates for the next years, ESF0 will show a small growth in Revenue. The Revenue will grow by 7.27% on average per year.
EPS Next Y14.76%
EPS Next 2Y14.31%
EPS Next 3Y14.14%
EPS Next 5Y13.34%
Revenue Next Year5.44%
Revenue Next 2Y5.6%
Revenue Next 3Y6.01%
Revenue Next 5Y7.27%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
ESF0 is valuated correctly with a Price/Earnings ratio of 16.62.
ESF0's Price/Earnings ratio is rather cheap when compared to the industry. ESF0 is cheaper than 83.33% of the companies in the same industry.
ESF0 is valuated rather cheaply when we compare the Price/Earnings ratio to 26.03, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 14.82 indicates a correct valuation of ESF0.
Based on the Price/Forward Earnings ratio, ESF0 is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.27, ESF0 is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.62 | ||
| Fwd PE | 14.82 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ESF0 is valued cheaper than 83.33% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ESF0 is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.9 | ||
| EV/EBITDA | 8.39 |
4.3 Compensation for Growth
ESF0's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
ESF0 has a very decent profitability rating, which may justify a higher PE ratio.
ESF0's earnings are expected to grow with 14.14% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.13
PEG (5Y)0.91
EPS Next 2Y14.31%
EPS Next 3Y14.14%
5. Dividend
5.1 Amount
With a yearly dividend of 0.99%, ESF0 is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.72, ESF0 pays a better dividend. On top of this ESF0 pays more dividend than 83.33% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, ESF0's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.99% |
5.2 History
On average, the dividend of ESF0 grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
ESF0 pays out 54.91% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of ESF0 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP54.91%
EPS Next 2Y14.31%
EPS Next 3Y14.14%
FRA:ESF0 (11/4/2025, 7:00:00 PM)
59.82
-0.3 (-0.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners37.21%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap10.90B
Revenue(TTM)6.89B
Net Income(TTM)374.80M
Analysts68.89
Price Target66.38 (10.97%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.99% |
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.91%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.33%
PT rev (3m)8.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.46%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.62 | ||
| Fwd PE | 14.82 | ||
| P/S | 1.58 | ||
| P/FCF | 13.9 | ||
| P/OCF | 8.29 | ||
| P/B | 2.35 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.39 |
EPS(TTM)3.6
EY6.02%
EPS(NY)4.04
Fwd EY6.75%
FCF(TTM)4.3
FCFY7.2%
OCF(TTM)7.22
OCFY12.07%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.13
PEG (5Y)0.91
Graham Number45.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROCE | 12.64% | ||
| ROIC | 9.79% | ||
| ROICexc | 10.74% | ||
| ROICexgc | 34.1% | ||
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% | ||
| FCFM | 11.37% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexgc growth 3Y-18.17%
ROICexgc growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.25 | ||
| Debt/EBITDA | 2.1 | ||
| Cap/Depr | 84.94% | ||
| Cap/Sales | 7.7% | ||
| Interest Coverage | 9.93 | ||
| Cash Conversion | 77.37% | ||
| Profit Quality | 209.21% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.66 |
F-Score7
WACC7.52%
ROIC/WACC1.3
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y14.76%
EPS Next 2Y14.31%
EPS Next 3Y14.14%
EPS Next 5Y13.34%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.44%
Revenue Next 2Y5.6%
Revenue Next 3Y6.01%
Revenue Next 5Y7.27%
EBIT growth 1Y14.03%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year86.11%
EBIT Next 3Y30.34%
EBIT Next 5Y22%
FCF growth 1Y113.13%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.31%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%
EUROFINS SCIENTIFIC / ESF0.DE FAQ
Can you provide the ChartMill fundamental rating for EUROFINS SCIENTIFIC?
ChartMill assigns a fundamental rating of 6 / 10 to ESF0.DE.
Can you provide the valuation status for EUROFINS SCIENTIFIC?
ChartMill assigns a valuation rating of 7 / 10 to EUROFINS SCIENTIFIC (ESF0.DE). This can be considered as Undervalued.
What is the profitability of ESF0 stock?
EUROFINS SCIENTIFIC (ESF0.DE) has a profitability rating of 6 / 10.
Can you provide the expected EPS growth for ESF0 stock?
The Earnings per Share (EPS) of EUROFINS SCIENTIFIC (ESF0.DE) is expected to grow by 14.76% in the next year.
Can you provide the dividend sustainability for ESF0 stock?
The dividend rating of EUROFINS SCIENTIFIC (ESF0.DE) is 4 / 10 and the dividend payout ratio is 54.91%.